But this assumes there is no risk to not doing it, which is false. Getting sick, suffering long term damage to your body, or dying are all very real risks of covid-19 that we already know about. We also have no idea what all the long term less evident negative effects are from covid-19. We have no idea if an asymptomatic covid infection does some sort of long term damage. So we are weighing the risk of treatment against the risk of the disease. People are naturally biased against active risk when compared to passive risk, so it is natural allow a high passive risk while worrying about a low active risk, but they are both just as real.
We need people to be confident in the long-term, as well as to have a solution quickly in the short-term.
[0] hence, for example, the use of the word “obscure” in the headline “The obscure maths theorem that governs the reliability of Covid testing”: https://www.theguardian.com/world/2021/apr/18/obscure-maths-...
So I’m skeptical of folks using 2nd order arguments about why going beyond rational approaches to risk is a good idea. People see overly risk-averse behavior by the FDA as evidence that the risk is actually high (relative to other stuff in their lives).
You can demonstrate a high degree of safety.
But demands to prove it can always ask for more more more.
You've skipped one of the usual phases, which is Phase IV trials. Cell lines -> Phases III trials aren't enough to catch long term side effects, because they are all done quickly.
An experimental mechanism passing Phase III trials is insufficient to prove it is safe. It proves that any negative events aren't evident quickly. The drug will probably prove to be safe in time, and I don't mind if people want to take that risk, I'm pretty free market. But it is, nevertheless, risky. We can't be confident that the body isn't using the same trick somewhere or somehow for something delicate that breaks quickly and shows symptoms slowly - biology is complex.
If the mechanism is novel then it wouldn't be suitable for a mass rollout to deal with this pandemic.